[HTML][HTML] Somatostatin analogues for the prevention of pancreatic fistula after open pancreatoduodenectomy: A nationwide analysis
BT Bootsma, VD Plat, T van de Brug, DE Huisman… - Pancreatology, 2022 - Elsevier
Background Somatostatin analogues (SA) are currently used to prevent postoperative
pancreatic fistula (POPF) development. However, its use is controversial. This study …
pancreatic fistula (POPF) development. However, its use is controversial. This study …
Somatostatin analogues for the prevention of pancreatic fistula after open pancreatoduodenectomy: A nationwide analysis
Dutch Pancreatic Cancer Group - Pancreatology, 2022 - researchinformation.amsterdamumc …
Background: Somatostatin analogues (SA) are currently used to prevent postoperative
pancreatic fistula (POPF) development. However, its use is controversial. This study …
pancreatic fistula (POPF) development. However, its use is controversial. This study …
Somatostatin analogues for the prevention of pancreatic fistula after open pancreatoduodenectomy: A nationwide analysis
BT Bootsma, VD Plat, T van de Brug… - … : official journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Somatostatin analogues (SA) are currently used to prevent postoperative
pancreatic fistula (POPF) development. However, its use is controversial. This study …
pancreatic fistula (POPF) development. However, its use is controversial. This study …
Somatostatin analogues for the prevention of pancreatic fistula after open pancreatoduodenectomy: A nationwide analysis
BT Bootsma, VD Plat, T Brug… - …, 2022 - scholarlypublications …
Background: Somatostatin analogues (SA) are currently used to prevent postoperative
pancreatic fistula (POPF) development. However, its use is controversial. This study …
pancreatic fistula (POPF) development. However, its use is controversial. This study …
[PDF][PDF] Somatostatin analogues for the prevention of pancreatic fistula after open pancreatoduodenectomy: A nationwide analysis
BT Bootsma, VD Plat, T Brug, DE Huisman, M Botti… - 2022 - repository.ubn.ru.nl
BACKGROUND: Somatostatin analogues (SA) are currently used to prevent postoperative
pancreatic fistula (POPF) development. However, its use is controversial. This study …
pancreatic fistula (POPF) development. However, its use is controversial. This study …
Somatostatin analogues for the prevention of pancreatic fistula after open pancreatoduodenectomy: A nationwide analysis
BT Bootsma, VD Plat, T van de Brug, DE Huisman… - …, 2022 - research.rug.nl
BACKGROUND: Somatostatin analogues (SA) are currently used to prevent postoperative
pancreatic fistula (POPF) development. However, its use is controversial. This study …
pancreatic fistula (POPF) development. However, its use is controversial. This study …
Somatostatin analogues for the prevention of pancreatic fistula after open pancreatoduodenectomy: A nationwide analysis.
BT Bootsma, VD Plat, T van de Brug… - … : Official Journal of the …, 2022 - europepmc.org
Background Somatostatin analogues (SA) are currently used to prevent postoperative
pancreatic fistula (POPF) development. However, its use is controversial. This study …
pancreatic fistula (POPF) development. However, its use is controversial. This study …
Somatostatin analogues for the prevention of pancreatic fistula after open pancreatoduodenectomy: A nationwide analysis
BT Bootsma, VD Plat, T van de Brug… - …, 2022 - cris.maastrichtuniversity.nl
Background: Somatostatin analogues (SA) are currently used to prevent postoperative
pancreatic fistula (POPF) development. However, its use is controversial. This study …
pancreatic fistula (POPF) development. However, its use is controversial. This study …